Price
CHART BY
Frequently asked questions
What is Phreesia's market capitalization?
The market capitalization of Phreesia is $631.26M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Phreesia's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Phreesia is 60.21. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Phreesia?
Phreesia's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.169. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Phreesia's stock?
Currently, 19 analysts cover Phreesia's stock, with a consensus target price of $13.94. Analyst ratings provide insights into the stock's expected performance.
What is Phreesia's revenue over the trailing twelve months?
Over the trailing twelve months, Phreesia reported a revenue of $507.79M.
What is the EBITDA for Phreesia?
Phreesia's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $62.98M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Phreesia?
Phreesia has a free cash flow of $75.34M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Phreesia have, and what sector and industry does it belong to?
Phreesia employs approximately 1,789 people. It operates in the Health Care sector, specifically within the Packaged Software industry.
What is the free float of Phreesia's shares?
The free float of Phreesia is 56.82M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $631.26M
- EPS (TTM)
- $0.169
- Free Float
- 56.82M
- P/E ratio (TTM)
- 60.21
- Revenue (TTM)
- $507.79M
- EBITDA (TTM)
- $62.98M
- Free Cashflow (TTM)
- $75.34M
Pricing
- 1D span
- $10.04$10.35
- 52W span
- $7.77$24.95
Analyst Ratings
The price target is $13.94 and the stock is covered by 19 analysts.
Buy
10
Hold
9
Sell
0
Information
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.
- Employees
- 1,789
- Industries
- Packaged Software
- Sector
- Health Care
Identifier
- Primary Ticker
- PHR
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet